InsidersTradesSigma
명문제약: management transactions · South Korea · DART (FSS)
DART:company-e788a1KR·DART (FSS)Mcap 55.5Bn€Healthcare
Browse the full management transaction log of 명문제약, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 명문제약 has logged 9 insider filings. Market capitalisation: €55.5bn. The latest transaction was disclosed on 30 April 2026 — Purchase. Among the most active insiders: 이장호. Every trade is openly available.
9
Insider Decl.
0
Thresholds
€11,558
8 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1635.00 €
Analyst consensus
Income statement
Revenue195.25 Bn€
Gross profit106.92 Bn€55% margin
Net income1.90 Bn€1.0% margin
Valuation
Beta0.35
Balance sheet & cash
Market cap55.51 Bn€
Total debt98.63 Bn€
Free Cash Flow−8.54 Bn€
Debt / Equity94%
Profitability & ownership
ROE1.4%
ROA1.6%
% insiders23.8%
% institutions0.1%
Last declaration on 30 April 2026
Declarations9 total
Executives●Other0DART
DART:20260311003642·details not loaded
9 of 9 declarations